Alexei Bogdanov to Excipients
This is a "connection" page, showing publications Alexei Bogdanov has written about Excipients.
Connection Strength
0.122
-
Reichstetter S, Castillo GM, Rubinstein I, Nishimoto-Ashfield A, Lai M, Jones CC, Banerjee AA, Banjeree A, Lyubimov A, Bloedow DC, Bogdanov A, Bolotin EM. Protected graft copolymer excipient leads to a higher acute maximum tolerated dose and extends residence time of vasoactive intestinal Peptide significantly better than sterically stabilized micelles. Pharm Res. 2013 Mar; 30(3):670-82.
Score: 0.099
-
Reichstetter S, Castillo GM, Lai M, Nishimoto-Ashfield A, Banerjee A, Bogdanov A, Lyubimov AV, Bolotin EM. Protected graft copolymer (PGC) basal formulation of insulin as potentially safer alternative to Lantus? (insulin-glargine): a streptozotocin-induced, diabetic Sprague Dawley rats study. Pharm Res. 2012 Apr; 29(4):1033-9.
Score: 0.023